Publications by authors named "Sinja Taavitsainen"

Claim this Profile
S
Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer.
Antti Kiviaho, Sini K Eerola, Heini M L Kallio, Maria K Andersen, Miina Hoikka, Sinja Taavitsainen

Nat Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer.
Nicolette M Fonseca, Corinne Maurice-Dror, Cameron Herberts, Wilson Tu, William Fan, Sinja Taavitsainen

Nat Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine.
Anssi Nurminen, Serafiina Jaatinen, Sinja Taavitsainen, Gunilla Högnäs, Tom Lesluyes

Genome Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fanconi anemia pathway regulation by FANCI in prostate cancer.
Heidi Kaljunen, Sinja Taavitsainen, Roosa Kaarijärvi, Eerika Takala, Ville Paakinaho

Front Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.
Shaolong Cao, Jennifer R Wang, Shuangxi Ji, Peng Yang, Yaoyi Dai, Sinja Taavitsainen

Nat Biotechnol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity.
Kirsi Ketola, Heidi Kaljunen, Sinja Taavitsainen, Roosa Kaarijärvi, Emmi Järvelä

Cancer Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition.
Matti Annala, Sinja Taavitsainen, Daniel J Khalaf, Gillian Vandekerkhove, Kevin Beja

Clin Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine.
Juho Jasu, Teemu Tolonen, Emmanuel S Antonarakis, Himisha Beltran, Susan Halabi, Sinja Taavitsainen

Eur Urol Open Sci· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response.
Konsta Kukkonen, Sinja Taavitsainen, Laura Huhtala, Joonas Uusi-Makela, Kirsi J Granberg

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer.
Gillian Vandekerkhove, Jean-Michel Lavoie, Matti Annala, Andrew J Murtha, Nora Sundahl, Sinja Taavitsainen

Nat Commun· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer.
Cameron Herberts, Andrew J Murtha, Simon Fu, Gang Wang, Elena Schönlau, Sinja Taavitsainen

Eur Urol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Hypermutation and Defective Mismatch Repair in ctDNA from Metastatic Prostate Cancer.
Elie Ritch, Simon Y F Fu, Cameron Herberts, Gang Wang, Evan W Warner, Sinja Taavitsainen

Clin Cancer Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial.
Daniel J Khalaf, Matti Annala, Sinja Taavitsainen, Daygen L Finch, Conrad Oja

Lancet Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer.
Sinja Taavitsainen, Matti Annala, Elisa Ledet, Kevin Beja, Patrick J Miller

JCO Precis Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent mutation of the untranslated region in prostate cancer.
Matti Annala, Sinja Taavitsainen, Gillian Vandekerkhove, Jack V W Bacon, Kevin Beja

Commun Biol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin 10 mutant zebrafish have an enhanced interferon gamma response and improved survival against a Mycobacterium marinum infection.
Sanna-Kaisa E Harjula, Markus J T Ojanen, Sinja Taavitsainen, Matti Nykter, Mika Rämet

Sci Rep· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer.
Matti Annala, Gillian Vandekerkhove, Daniel Khalaf, Sinja Taavitsainen, Kevin Beja

Cancer Discov· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis